Presentation is loading. Please wait.

Presentation is loading. Please wait.

Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation.

Similar presentations


Presentation on theme: "Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation."— Presentation transcript:

1 Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with Beta-Thalassemia Major by M Akif Yesilipek, Gulsun Karasu, Zuhre Kaya, Baris B Kuskonmaz, Vedat Uygun, Ilkiz Dag, Asli Birkent, and Mehmet Ertem Blood Volume 126(23):959-959 December 3, 2015 ©2015 by American Society of Hematology

2 M Akif Yesilipek et al. Blood 2015;126:959 ©2015 by American Society of Hematology

3 M Akif Yesilipek et al. Blood 2015;126:959 ©2015 by American Society of Hematology

4 M Akif Yesilipek et al. Blood 2015;126:959 ©2015 by American Society of Hematology


Download ppt "Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation."

Similar presentations


Ads by Google